Search by Drug Name or NDC
NDC 24689-0122-02 Guaifenesin 400 mg/1 Details
Guaifenesin 400 mg/1
Guaifenesin is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by APNAR PHARMA LP. The primary component is GUAIFENESIN.
MedlinePlus Drug Summary
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 24689-0122-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
| NDC | 24689-0122 |
|---|---|
| Product ID | 24689-122_f17dd3fb-510e-011b-e053-2a95a90a57e4 |
| Associated GPIs | |
| GCN Sequence Number | 051583 |
| GCN Sequence Number Description | guaifenesin TABLET 400 MG ORAL |
| HIC3 | B3J |
| HIC3 Description | EXPECTORANTS |
| GCN | 18906 |
| HICL Sequence Number | 000271 |
| HICL Sequence Number Description | GUAIFENESIN |
| Brand/Generic | Generic |
| Proprietary Name | Guaifenesin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Guaifenesin |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 400 |
| Active Ingredient Units | mg/1 |
| Substance Name | GUAIFENESIN |
| Labeler Name | APNAR PHARMA LP |
| Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24689-0122-02 (24689012202)
| NDC Package Code | 24689-122-02 |
|---|---|
| Billing NDC | 24689012202 |
| Package | 500 TABLET in 1 BOTTLE (24689-122-02) |
| Marketing Start Date | 2022-12-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |